Page 82 - IngresoDr.MtzLanao

Gibaldi M, Perrier D. Pharmacokinetics. Pharmacy and related subject series, Swarbrick J (Ed).
Marcel Dekker. New York. 1975.

Godfrin Y, Bax BE (2012). Enzyme bioreactors as drugs. Drugs Future., 37(4): 263–272.

Gómez Amoza JL (2017). Formas sólidas orales de liberación modificada (Capítulo 3) (Vol III pp
113-135). R Martínez Pacheco (Ed). En Tratado de Tecnología Farmacéutica (vol. III): Formas de
Dosificación. Editorial Síntesis.

Goyanes A, Kobayashi M, Martínez-Pacheco R, Gaisford S, Basit AW (2016). Fused-filament 3D
printing of drug products: Microstructure analysis and drug release characteristics of PVA-based
caplets. Int J Pharm.; 514(1): 290-295.

Gyürkés M, Madarász L, Köte Á, Domokos A, Mészáros D, Beke ÁK, Nagy B, Marosi G, Pataki H,
Nagy ZK, Farkas A (2020). Process Design of Continuous Powder Blending Using Residence Time
Distribution and Feeding Models. Pharmaceutics., 12(11): 1119.

Grottkau BE, Hui Z, Pang Y.A (2020). Novel 3D Bioprinter Using Direct-Volumetric Drop-On-
Demand Technology for Fabricating Micro-Tissues and Drug-Delivery. Int J Mol Sci., 21(10): 3482.

Guidance for Industry PAT. A framework for Innovative pharmaceutical Development,
Manufacturing and Quality Assurance. Food and Drug Administration (FDA). September. 2004.

Guldberg CM, Waage P (1867). Untersuchungen uber die chemischen affinitaten.

Gupta P, Kateja N, Mishra S, Kaur H, Rathore AS (2020). Economic assessment of continuous
processing for manufacturing of biotherapeutics. Biotechnol Prog., 10: e3108.

Gutiérrez-Millan C, Calvo Díaz C, Lanao JM, Colino CI (2021). Advances in Exosomes-Based Drug
Delivery Systems. Macromol Biosci., 21(1): e2000269.

Gutiérrez Millán C, Colino Gandarillas CI, Sayalero Marinero ML, Lanao JM (2012). Cell-based
drug-delivery platforms. Ther Deliv. 3(1): 25-41.

Gutiérrez Millán C, Zarzuelo Castañeda A, Sayalero Marinero ML, Lanao JM (2004). Factors
associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood
Cells Mol Dis., 33(2): 132-140.

Gutiérrez Millán C, Zarzuelo Castañeda A, González López F, Sayalero Marinero ML, Lanao JM
(2008). Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
J Antimicrob Chemother., 61(2): 375-381.

Gutiérrez Millán C, Bax BE, Castañeda AZ, Marinero ML, Lanao JM (2008). In vitro studies of
amikacin-loaded human carrier erythrocytes. Transl Res. 152(2): 59-66.

Gutiérrez-Millan C, Calvo Díaz C, Lanao JM, Colino CI (2021). Advances in Exosomes-Based Drug
Delivery Systems. Macromol Biosci., 21(1): e2000269.

Hahn SM. Accelerating the Adoption of Advanced Manufacturing Technologies to Strengthen
Our Public Health Infrastructure. FDA. 2021.

Hammel P, Fabienne P, Mineur L, Metges JP, Andre T, De La Fouchardiere C, Louvet C, El Hajbi
F, Faroux R, Guimbaud R, Tougeron D, Bouche O, Lecomte T, Rebischung C, Tournigand C, Cros

80